Loading provider…
Loading provider…
Radiation Oncology Physician in Indianapolis, IN
NPI: 1194725937Primary Practice Location
COMMUNITY HOSPITAL EAST
8075 N Shadeland Ave, Indianapolis, IN
Primary Employer
Community Health Network
ecommunity.com
HQ Phone
Get MD Daniel's Phone Numberphone_androidMobile
Get MD Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNV State Medical License
IN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 165 | 211 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 78 | 99 |
| 3 | 77014Ct scan guidance for insertion of radiation therapy fields | 78 | 525 |
| 4 | 77334Design and construction of complex radiation treatment device | 58 | 156 |
| 5 | 77263Complex radiation therapy planning | 56 | 62 |
Authors: Ethan Ludmir, Stephen Chun, Wendy Woodward, David Ramirez, Amol Ghia, Shalin Shah, Chad Tang, Mediget Teshome, Alexander Sherry, Abenaa Brewster, Carlos Barcenas, Simona Shaitelman, Melissa Mitchell, Jay Paul Reddy, Daniel Gomez, Tharakeswara Bathala, Benjamin Smith
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2024-10-30
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Pemetrexed Disodium, DRUG: Erlotinib Hydrochloride, RADIATION: Stereotactic Body Radiation Therapy (SBRT), RADIATION: Intensity-Modulated Radiation Therapy (IMRT), RADIATION: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Etoposide, RADIATION: 3-Dimensional Conformal Radiation Therapy
Lead Sponsor: Canadian Cancer Trials Group
Collaborators: NRG Oncology, Alliance for Clinical Trials in Oncology
Intervention / Treatment: PROCEDURE: Stereotactic Radiosurgery (SRS), DRUG: Memantine, RADIATION: Hippocampal-avoidant (HA-WBRT) Radiotherapy